25 XP   0   0   10

Waverley Pharma Inc
Buy, Hold or Sell?

Let's analyse Waverley Pharma Inc together

PenkeI guess you are interested in Waverley Pharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Waverley Pharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Waverley Pharma Inc

I send you an email if I find something interesting about Waverley Pharma Inc.

Quick analysis of Waverley Pharma Inc (30 sec.)










What can you expect buying and holding a share of Waverley Pharma Inc? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$0.00
Expected worth in 1 year
C$-0.02
How sure are you?
11.1%

+ What do you gain per year?

Total Gains per Share
C$-0.02
Return On Investment
-113.3%

For what price can you sell your share?

Current Price per Share
C$0.02
Expected price per share
C$0.02 - C$0.035
How sure are you?
50%

1. Valuation of Waverley Pharma Inc (5 min.)




Live pricePrice per Share (EOD)

C$0.02

Intrinsic Value Per Share

C$-0.46 - C$-0.55

Total Value Per Share

C$-0.46 - C$-0.55

2. Growth of Waverley Pharma Inc (5 min.)




Is Waverley Pharma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$140.5k$1.1m-$699.7k-151.2%

How much money is Waverley Pharma Inc making?

Current yearPrevious yearGrowGrow %
Making money-$200.5k-$132.4k-$68.1k-34.0%
Net Profit Margin-221.6%-50.3%--

How much money comes from the company's main activities?

3. Financial Health of Waverley Pharma Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#833 / 1007

Most Revenue
#508 / 1007

Most Profit
#202 / 1007

Most Efficient
#520 / 1007

What can you expect buying and holding a share of Waverley Pharma Inc? (5 min.)

Welcome investor! Waverley Pharma Inc's management wants to use your money to grow the business. In return you get a share of Waverley Pharma Inc.

What can you expect buying and holding a share of Waverley Pharma Inc?

First you should know what it really means to hold a share of Waverley Pharma Inc. And how you can make/lose money.

Speculation

The Price per Share of Waverley Pharma Inc is C$0.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Waverley Pharma Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Waverley Pharma Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.00. Based on the TTM, the Book Value Change Per Share is C$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Waverley Pharma Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.00-21.0%0.00-20.8%0.00-12.3%0.00-15.7%0.00-20.4%
Usd Book Value Change Per Share0.00-21.0%0.00-20.7%0.00-1.7%0.00-13.2%0.000.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-21.0%0.00-20.7%0.00-1.7%0.00-13.2%0.000.5%
Usd Price Per Share0.02-0.03-0.04-0.06-0.10-
Price to Earnings Ratio-1.09--1.63--9.64-100.12-37.89-
Price-to-Total Gains Ratio-4.36--6.50--24.19--41.58--169.94-
Price to Book Ratio7.02-4.10-2.07-2.72--38.59-
Price-to-Total Gains Ratio-4.36--6.50--24.19--41.58--169.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.014616
Number of shares68418
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (68418 shares)-283.23-180.18
Gains per Year (68418 shares)-1,132.92-720.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1133-11430-721-731
20-2266-22760-1441-1452
30-3399-34090-2162-2173
40-4532-45420-2883-2894
50-5665-56750-3604-3615
60-6798-68080-4324-4336
70-7930-79410-5045-5057
80-9063-90740-5766-5778
90-10196-102070-6486-6499
100-11329-113400-7207-7220

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.026.00.03.7%1.026.00.03.7%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%3.024.00.011.1%3.024.00.011.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.027.00.0%0.00.027.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%3.024.00.011.1%3.024.00.011.1%

Fundamentals of Waverley Pharma Inc

About Waverley Pharma Inc

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes cancer therapeutics in the United Kingdom. It focuses on the generic oncology injectable products. The company sells generic oncology products comprising capecitabine, temozolomide, and erlotinib. Its products under development include injectable generic chemotherapy drugs, such as Pemetrexed for the treatment of non-small cell lung cancer and other indications; and Bortezomib to treat multiple myeloma and other indications. Waverley Pharma Inc. is headquartered in Winnipeg, Canada.

Fundamental data was last updated by Penke on 2024-05-01 02:27:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Waverley Pharma Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Waverley Pharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Waverley Pharma Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -322.6% means that $-3.23 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Waverley Pharma Inc:

  • The MRQ is -322.6%. The company is making a huge loss. -2
  • The TTM is -221.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-322.6%TTM-221.6%-101.0%
TTM-221.6%YOY-50.3%-171.4%
TTM-221.6%5Y-99.2%-122.5%
5Y-99.2%10Y-73.5%-25.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-322.6%-207.2%-115.4%
TTM-221.6%-214.6%-7.0%
YOY-50.3%-281.4%+231.1%
5Y-99.2%-428.1%+328.9%
10Y-73.5%-595.4%+521.9%
1.1.2. Return on Assets

Shows how efficient Waverley Pharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Waverley Pharma Inc to the Biotechnology industry mean.
  • -15.2% Return on Assets means that Waverley Pharma Inc generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Waverley Pharma Inc:

  • The MRQ is -15.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.2%TTM-11.8%-3.3%
TTM-11.8%YOY-5.5%-6.3%
TTM-11.8%5Y-6.8%-5.0%
5Y-6.8%10Y-13.8%+7.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.2%-12.9%-2.3%
TTM-11.8%-12.3%+0.5%
YOY-5.5%-11.2%+5.7%
5Y-6.8%-13.5%+6.7%
10Y-13.8%-15.1%+1.3%
1.1.3. Return on Equity

Shows how efficient Waverley Pharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Waverley Pharma Inc to the Biotechnology industry mean.
  • -161.2% Return on Equity means Waverley Pharma Inc generated $-1.61 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Waverley Pharma Inc:

  • The MRQ is -161.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -68.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-161.2%TTM-68.4%-92.8%
TTM-68.4%YOY-11.2%-57.2%
TTM-68.4%5Y-21.3%-47.1%
5Y-21.3%10Y-18.4%-2.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-161.2%-16.5%-144.7%
TTM-68.4%-15.7%-52.7%
YOY-11.2%-14.1%+2.9%
5Y-21.3%-18.8%-2.5%
10Y-18.4%-19.7%+1.3%

1.2. Operating Efficiency of Waverley Pharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Waverley Pharma Inc is operating .

  • Measures how much profit Waverley Pharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Waverley Pharma Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Waverley Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-106.5%+106.5%
TTM-106.5%YOY-43.0%-63.5%
TTM-106.5%5Y-78.0%-28.5%
5Y-78.0%10Y-57.8%-20.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--287.3%+287.3%
TTM-106.5%-226.2%+119.7%
YOY-43.0%-287.8%+244.8%
5Y-78.0%-459.1%+381.1%
10Y-57.8%-598.1%+540.3%
1.2.2. Operating Ratio

Measures how efficient Waverley Pharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.67 means that the operating costs are $4.67 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Waverley Pharma Inc:

  • The MRQ is 4.672. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.953. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.672TTM3.953+0.719
TTM3.953YOY2.415+1.537
TTM3.9535Y2.894+1.059
5Y2.89410Y2.143+0.750
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6723.246+1.426
TTM3.9533.303+0.650
YOY2.4153.753-1.338
5Y2.8945.557-2.663
10Y2.1437.396-5.253

1.3. Liquidity of Waverley Pharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Waverley Pharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.17 means the company has $0.17 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Waverley Pharma Inc:

  • The MRQ is 0.167. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.274. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.167TTM0.274-0.106
TTM0.274YOY0.628-0.354
TTM0.2745Y1.172-0.898
5Y1.17210Y1.777-0.606
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1673.821-3.654
TTM0.2744.161-3.887
YOY0.6285.313-4.685
5Y1.1726.113-4.941
10Y1.7776.474-4.697
1.3.2. Quick Ratio

Measures if Waverley Pharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Waverley Pharma Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.07 means the company can pay off $0.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Waverley Pharma Inc:

  • The MRQ is 0.069. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.070. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.069TTM0.070-0.001
TTM0.070YOY0.324-0.253
TTM0.0705Y0.305-0.235
5Y0.30510Y0.240+0.066
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0693.474-3.405
TTM0.0703.993-3.923
YOY0.3245.388-5.064
5Y0.3056.105-5.800
10Y0.2406.442-6.202

1.4. Solvency of Waverley Pharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Waverley Pharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Waverley Pharma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.91 means that Waverley Pharma Inc assets are financed with 90.6% credit (debt) and the remaining percentage (100% - 90.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Waverley Pharma Inc:

  • The MRQ is 0.906. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.743. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.906TTM0.743+0.162
TTM0.743YOY0.511+0.233
TTM0.7435Y0.462+0.282
5Y0.46210Y4.875-4.413
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9060.347+0.559
TTM0.7430.340+0.403
YOY0.5110.272+0.239
5Y0.4620.368+0.094
10Y4.8750.388+4.487
1.4.2. Debt to Equity Ratio

Measures if Waverley Pharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Waverley Pharma Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 963.4% means that company has $9.63 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Waverley Pharma Inc:

  • The MRQ is 9.634. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.212. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ9.634TTM4.212+5.422
TTM4.212YOY1.045+3.167
TTM4.2125Y1.396+2.816
5Y1.39610Y1.075+0.321
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.6340.395+9.239
TTM4.2120.411+3.801
YOY1.0450.339+0.706
5Y1.3960.438+0.958
10Y1.0750.469+0.606

2. Market Valuation of Waverley Pharma Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Waverley Pharma Inc generates.

  • Above 15 is considered overpriced but always compare Waverley Pharma Inc to the Biotechnology industry mean.
  • A PE ratio of -1.09 means the investor is paying $-1.09 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Waverley Pharma Inc:

  • The EOD is -0.871. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.089. Based on the earnings, the company is expensive. -2
  • The TTM is -1.628. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.871MRQ-1.089+0.218
MRQ-1.089TTM-1.628+0.539
TTM-1.628YOY-9.639+8.012
TTM-1.6285Y100.118-101.746
5Y100.11810Y37.893+62.225
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.871-2.437+1.566
MRQ-1.089-2.599+1.510
TTM-1.628-2.764+1.136
YOY-9.639-4.018-5.621
5Y100.118-6.401+106.519
10Y37.893-6.590+44.483
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Waverley Pharma Inc:

  • The EOD is -1.008. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.260. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.586. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.008MRQ-1.260+0.252
MRQ-1.260TTM-3.586+2.326
TTM-3.586YOY11.236-14.822
TTM-3.5865Y-4.535+0.949
5Y-4.53510Y33.583-38.118
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.008-3.111+2.103
MRQ-1.260-3.321+2.061
TTM-3.586-3.598+0.012
YOY11.236-5.480+16.716
5Y-4.535-8.353+3.818
10Y33.583-8.955+42.538
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Waverley Pharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.02 means the investor is paying $7.02 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Waverley Pharma Inc:

  • The EOD is 5.616. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.020. Based on the equity, the company is overpriced. -1
  • The TTM is 4.105. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.616MRQ7.020-1.404
MRQ7.020TTM4.105+2.916
TTM4.105YOY2.072+2.032
TTM4.1055Y2.718+1.387
5Y2.71810Y-38.590+41.307
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.6162.051+3.565
MRQ7.0202.143+4.877
TTM4.1052.120+1.985
YOY2.0722.878-0.806
5Y2.7183.601-0.883
10Y-38.5903.972-42.562
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Waverley Pharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.006-0.006-1%0.000-92%-0.004-37%0.000-4452%
Book Value Per Share--0.0040.012-70%0.029-88%0.038-91%0.040-91%
Current Ratio--0.1670.274-39%0.628-73%1.172-86%1.777-91%
Debt To Asset Ratio--0.9060.743+22%0.511+77%0.462+96%4.875-81%
Debt To Equity Ratio--9.6344.212+129%1.045+822%1.396+590%1.075+797%
Dividend Per Share----0%-0%-0%-0%
Eps---0.006-0.006-1%-0.003-42%-0.004-25%-0.006-3%
Free Cash Flow Per Share---0.005-0.003-32%-0.001-75%-0.003-33%-0.003-32%
Free Cash Flow To Equity Per Share---0.005-0.002-57%0.000-97%-0.003-44%0.010-152%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.549--------
Intrinsic Value_10Y_min---0.460--------
Intrinsic Value_1Y_max---0.016--------
Intrinsic Value_1Y_min---0.016--------
Intrinsic Value_3Y_max---0.079--------
Intrinsic Value_3Y_min---0.075--------
Intrinsic Value_5Y_max---0.177--------
Intrinsic Value_5Y_min---0.161--------
Market Cap1080000.000-25%1350000.0001957500.000-31%3307500.000-59%4581446.200-71%7312263.481-82%
Net Profit Margin---3.226-2.216-31%-0.503-84%-0.992-69%-0.735-77%
Operating Margin----1.0650%-0.4300%-0.7800%-0.5780%
Operating Ratio--4.6723.953+18%2.415+93%2.894+61%2.143+118%
Pb Ratio5.616-25%7.0204.105+71%2.072+239%2.718+158%-38.590+650%
Pe Ratio-0.871+20%-1.089-1.628+49%-9.639+785%100.118-101%37.893-103%
Price Per Share0.020-25%0.0250.036-31%0.061-59%0.085-71%0.135-82%
Price To Free Cash Flow Ratio-1.008+20%-1.260-3.586+185%11.236-111%-4.535+260%33.583-104%
Price To Total Gains Ratio-3.484+20%-4.355-6.503+49%-24.185+455%-41.582+855%-169.937+3802%
Quick Ratio--0.0690.070-2%0.324-79%0.305-77%0.240-71%
Return On Assets---0.152-0.118-22%-0.055-64%-0.068-55%-0.138-9%
Return On Equity---1.612-0.684-58%-0.112-93%-0.213-87%-0.184-89%
Total Gains Per Share---0.006-0.006-1%0.000-92%-0.004-37%0.000-4452%
Usd Book Value--140532.109462748.224-70%1162461.088-88%1502778.972-91%1604709.857-91%
Usd Book Value Change Per Share---0.004-0.004-1%0.000-92%-0.003-37%0.000-4452%
Usd Book Value Per Share--0.0030.009-70%0.022-88%0.027-91%0.029-91%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.004-0.004-1%-0.002-42%-0.003-25%-0.004-3%
Usd Free Cash Flow---195793.013-132940.193-32%-49510.604-75%-132245.385-32%-132989.441-32%
Usd Free Cash Flow Per Share---0.004-0.002-32%-0.001-75%-0.002-33%-0.002-32%
Usd Free Cash Flow To Equity Per Share---0.004-0.002-57%0.000-97%-0.002-44%0.007-152%
Usd Market Cap789264.000-25%986580.0001430541.000-31%2417121.000-59%3348120.883-71%5343802.152-82%
Usd Price Per Share0.015-25%0.0180.026-31%0.045-59%0.062-71%0.099-82%
Usd Profit---226519.499-200569.522-11%-132416.941-42%-166203.469-27%-218610.917-3%
Usd Revenue--70219.64999134.482-29%280328.303-75%223581.866-69%165616.197-58%
Usd Total Gains Per Share---0.004-0.004-1%0.000-92%-0.003-37%0.000-4452%
 EOD+3 -5MRQTTM+2 -30YOY+3 -295Y+3 -2910Y+5 -27

3.2. Fundamental Score

Let's check the fundamental score of Waverley Pharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.871
Price to Book Ratio (EOD)Between0-15.616
Net Profit Margin (MRQ)Greater than0-3.226
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.069
Current Ratio (MRQ)Greater than10.167
Debt to Asset Ratio (MRQ)Less than10.906
Debt to Equity Ratio (MRQ)Less than19.634
Return on Equity (MRQ)Greater than0.15-1.612
Return on Assets (MRQ)Greater than0.05-0.152
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Waverley Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.311
Ma 20Greater thanMa 500.030
Ma 50Greater thanMa 1000.030
Ma 100Greater thanMa 2000.027
OpenGreater thanClose0.020
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets2,045
Total Liabilities1,853
Total Stockholder Equity192
 As reported
Total Liabilities 1,853
Total Stockholder Equity+ 192
Total Assets = 2,045

Assets

Total Assets2,045
Total Current Assets310
Long-term Assets1,735
Total Current Assets
Cash And Cash Equivalents 32
Net Receivables 128
Inventory 89
Total Current Assets  (as reported)310
Total Current Assets  (calculated)249
+/- 61
Long-term Assets
Intangible Assets 1,438
Long-term Assets Other 297
Long-term Assets  (as reported)1,735
Long-term Assets  (calculated)1,735
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,853
Long-term Liabilities0
Total Stockholder Equity192
Total Current Liabilities
Short Long Term Debt 1,138
Accounts payable 557
Total Current Liabilities  (as reported)1,853
Total Current Liabilities  (calculated)1,695
+/- 158
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)192
Total Stockholder Equity (calculated)0
+/- 192
Other
Capital Stock7,000
Common Stock Shares Outstanding 54,000
Net Debt 1,107
Net Invested Capital 1,330
Net Working Capital -1,543



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
0
31
302
6,658
6,210
5,304
5,131
5,237
5,156
4,920
4,464
4,394
4,160
3,538
3,593
3,492
3,304
3,354
3,111
3,684
3,158
3,304
2,871
2,687
2,497
2,215
2,045
2,0452,2152,4972,6872,8713,3043,1583,6843,1113,3543,3043,4923,5933,5384,1604,3944,4644,9205,1565,2375,1315,3046,2106,658302310
   > Total Current Assets 
0
31
53
4,902
4,405
3,460
3,319
3,327
3,285
3,087
2,609
2,539
2,134
1,594
1,694
1,682
1,519
1,598
1,317
1,446
980
1,106
710
633
549
373
310
3103735496337101,1069801,4461,3171,5981,5191,6821,6941,5942,1342,5392,6093,0873,2853,3273,3193,4604,4054,90253310
       Cash And Cash Equivalents 
0
4
28
4,856
4,337
3,379
3,206
2,943
2,832
2,365
1,751
1,477
998
559
723
710
630
259
138
158
143
133
126
134
135
48
32
32481351341261331431581382596307107235599981,4771,7512,3652,8322,9433,2063,3794,3374,8562840
       Net Receivables 
0
1
1
28
50
69
96
328
250
415
442
927
842
437
399
456
401
605
692
702
522
527
418
191
129
33
128
1283312919141852752270269260540145639943784292744241525032896695028110
   > Long-term Assets 
0
0
0
0
0
0
0
0
1,871
1,834
1,855
1,855
2,026
1,944
1,899
1,810
1,785
1,756
1,794
2,238
2,179
2,198
2,161
2,055
1,948
1,842
1,735
1,7351,8421,9482,0552,1612,1982,1792,2381,7941,7561,7851,8101,8991,9442,0261,8551,8551,8341,87100000000
       Intangible Assets 
0
0
249
1,756
1,805
1,844
1,812
1,910
1,871
1,834
1,855
1,855
2,026
1,944
1,899
1,810
1,785
1,756
1,794
1,758
1,725
1,770
1,760
1,679
1,599
1,518
1,438
1,4381,5181,5991,6791,7601,7701,7251,7581,7941,7561,7851,8101,8991,9442,0261,8551,8551,8341,8711,9101,8121,8441,8051,75624900
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
480
454
428
402
0
349
323
0
032334904024284544800000000000000000000
> Total Liabilities 
12
58
337
1,601
1,416
1,034
1,018
1,264
1,340
1,324
1,304
1,548
1,376
1,059
1,145
1,449
1,425
1,663
1,592
1,895
1,563
1,741
1,455
1,596
1,750
1,712
1,853
1,8531,7121,7501,5961,4551,7411,5631,8951,5921,6631,4251,4491,1451,0591,3761,5481,3041,3241,3401,2641,0181,0341,4161,6013375812
   > Total Current Liabilities 
12
58
337
660
449
1,034
1,018
1,264
1,340
1,324
1,304
1,548
1,376
1,019
1,105
1,409
1,385
1,623
1,552
1,895
1,563
1,741
1,455
1,596
1,750
1,712
1,853
1,8531,7121,7501,5961,4551,7411,5631,8951,5521,6231,3851,4091,1051,0191,3761,5481,3041,3241,3401,2641,0181,0344496603375812
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
262
102
75
504
702
787
887
1,138
1,138887787702504751022620000000000000000000
       Accounts payable 
44
5
4
133
22
32
34
227
338
342
310
572
525
405
504
834
818
1,064
979
1,062
870
1,045
529
737
805
586
557
5575868057375291,0458701,0629791,0648188345044055255723103423382273432221334544
       Other Current Liabilities 
0
52
333
33
0
3
9
10
17
16
19
0
0
0
0
0
0
0
0
0
0
27
37
0
0
43
0
04300372700000000001916171093033333520
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
40
40
40
40
40
40
0
0
0
0
0
0
0
0
000000004040404040400000000000000
       Other Liabilities 
0
0
0
941
967
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000967941000
> Total Stockholder Equity
-12
-27
-35
5,057
4,794
4,270
4,113
3,972
3,816
3,596
3,160
2,845
2,783
2,478
2,448
2,043
1,879
1,692
1,518
1,789
1,595
1,562
1,416
1,091
747
502
192
1925027471,0911,4161,5621,5951,7891,5181,6921,8792,0432,4482,4782,7832,8453,1603,5963,8163,9724,1134,2704,7945,057-35-27-12
   Common Stock
0
0
0
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
7,000
0
7,000
7,000
0
07,0007,00007,0007,0007,0007,0007,0007,0007,0007,0007,0007,0007,0007,0007,0007,0007,0007,0007,0007,0007,0007,000000
   Retained Earnings -8,062-7,752-7,511-7,171-6,964-6,842-6,818-6,507-6,239-6,032-5,884-5,711-5,388-5,390-5,187-5,005-4,673-4,192-3,962-3,790-3,540-3,328-2,717-2,369-33-27-12
   Capital Surplus 000000000000000000000000000
   Treasury Stock000000000000000000000000000
   Other Stockholders Equity 
0
26
-2
244
265
288
271
328
301
200
206
24
123
34
-10
-56
-47
-88
-52
487
604
595
570
453
448
444
0
0444448453570595604487-52-88-47-56-103412324206200301328271288265244-2260



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue543
Cost of Revenue-381
Gross Profit161161
 
Operating Income (+$)
Gross Profit161
Operating Expense-1,628
Operating Income-1,085-1,466
 
Operating Expense (+$)
Research Development233
Selling General Administrative1,077
Selling And Marketing Expenses-
Operating Expense1,6281,310
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-57
Net Interest Income-57
 
Pretax Income (+$)
Operating Income-1,085
Net Interest Income-57
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,098-1,130
EBIT - interestExpense = 0
-1,098
-1,098
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--1,098
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,098
Tax Provision--
Net Income From Continuing Ops-1,098-1,098
Net Income-1,098
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net4557
 

Technical Analysis of Waverley Pharma Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Waverley Pharma Inc. The general trend of Waverley Pharma Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Waverley Pharma Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Waverley Pharma Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.035 < 0.035 < 0.035.

The bearish price targets are: 0.02 > 0.02 > 0.02.

Tweet this
Waverley Pharma Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Waverley Pharma Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Waverley Pharma Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Waverley Pharma Inc. The current macd is -0.00254672.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Waverley Pharma Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Waverley Pharma Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Waverley Pharma Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Waverley Pharma Inc Daily Moving Average Convergence/Divergence (MACD) ChartWaverley Pharma Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Waverley Pharma Inc. The current adx is 42.63.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Waverley Pharma Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Waverley Pharma Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Waverley Pharma Inc. The current sar is 0.03271685.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Waverley Pharma Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Waverley Pharma Inc. The current rsi is 33.31. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Waverley Pharma Inc Daily Relative Strength Index (RSI) ChartWaverley Pharma Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Waverley Pharma Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Waverley Pharma Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Waverley Pharma Inc Daily Stochastic Oscillator ChartWaverley Pharma Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Waverley Pharma Inc. The current cci is -129.35323383.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Waverley Pharma Inc Daily Commodity Channel Index (CCI) ChartWaverley Pharma Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Waverley Pharma Inc. The current cmo is -40.72786183.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Waverley Pharma Inc Daily Chande Momentum Oscillator (CMO) ChartWaverley Pharma Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Waverley Pharma Inc. The current willr is -75.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Waverley Pharma Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Waverley Pharma Inc Daily Williams %R ChartWaverley Pharma Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Waverley Pharma Inc.

Waverley Pharma Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Waverley Pharma Inc. The current atr is 0.00298396.

Waverley Pharma Inc Daily Average True Range (ATR) ChartWaverley Pharma Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Waverley Pharma Inc. The current obv is -262,100.

Waverley Pharma Inc Daily On-Balance Volume (OBV) ChartWaverley Pharma Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Waverley Pharma Inc. The current mfi is 19.76.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Waverley Pharma Inc Daily Money Flow Index (MFI) ChartWaverley Pharma Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Waverley Pharma Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Waverley Pharma Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Waverley Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.311
Ma 20Greater thanMa 500.030
Ma 50Greater thanMa 1000.030
Ma 100Greater thanMa 2000.027
OpenGreater thanClose0.020
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Waverley Pharma Inc with someone you think should read this too:
  • Are you bullish or bearish on Waverley Pharma Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Waverley Pharma Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Waverley Pharma Inc

I send you an email if I find something interesting about Waverley Pharma Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Waverley Pharma Inc.

Receive notifications about Waverley Pharma Inc in your mailbox!